How to Respond to an FDA Warning Letter: the 15-Day Plan
Updated August 2026 · GMPSignal team
Direct answer: You have 15 working days to respond to an FDA warning letter. A credible response acknowledges each violation specifically, shows a root-cause analysis, commits to a dated CAPA plan with interim risk controls, and attaches evidence. Generic promises, blaming individuals, or disputing everything are the three fastest routes to escalation.
The clock: what "15 working days" really means
The FDA expects a written response within 15 working days of receiving a warning letter. That is roughly three calendar weeks — not long when legal review, executive sign-off and translated evidence are involved. Two practical notes: the clock starts at receipt, not the letter's date, and if a complete response is genuinely impossible in time, send an interim response that commits to a dated completion plan. Silence is treated as refusal.
Anatomy of a response the FDA actually accepts
Reviewers read hundreds of these. The ones that close out share the same skeleton:
- Restate each violation verbatim, numbered exactly as the letter does. Never summarize the FDA's language into something softer.
- Root cause, not symptoms. "Analyst error" is a symptom. Why was the error possible, undetected, and uncorrected? Weak investigations are themselves a top citation — see our breakdown of how warning letters work.
- CAPA with dates and owners. Every corrective action needs a completion date, a responsible role, and an effectiveness check. "We will retrain staff" without a date reads as evasion.
- Interim risk control. What protects patients today, before the fix lands? Quarantine, additional testing, third-party oversight — say it explicitly.
- Evidence attached. Revised SOPs, training records, validation protocols, photographs. Claims without exhibits are treated as claims.
- Scope beyond the citation. The FDA expects you to ask: where else could this failure exist? A response limited strictly to the cited batch or line signals a reactive quality culture.
The five mistakes that trigger escalation
Escalation after a warning letter looks like import alert, seizure, injunction or consent decree. In the letters we track at GMPSignal — 1794 enforcement documents and counting — the same response failures repeat:
- Arguing every point. You can respectfully disagree with a specific finding with data, but a wholesale rebuttal tells the district office you have not understood the problem.
- Over-promising. Committing to remediate an entire quality system in 30 days destroys credibility instantly.
- Consultant-speak without ownership. Hiring a remediation firm helps, but the FDA holds your quality unit responsible under 21 CFR 211.22.
- Ignoring distributed product. If violative product is on the market, the response must address recall or a documented risk justification.
- Missing the systemic read-across. One data-integrity finding in QC implies a question about every laboratory record. Answer it before the FDA asks.
A realistic 15-day timeline
- Days 1–2: Assemble the team (QA, operations, regulatory, legal). Read the letter against the original 483 and your 483 response — the gap between them is usually why the letter was issued.
- Days 3–6: Root-cause investigations on each item; freeze and document interim controls.
- Days 7–10: Draft CAPA plan with dates; commission any third-party audit; collect evidence exhibits.
- Days 11–13: Cross-functional review; verify every commitment is achievable — you will be held to each date.
- Days 14–15: Executive sign-off, quality-unit sign-off, submit to the district office and the addressee named in the letter.
After you respond: the long tail
Expect follow-up questions, a re-inspection, and months of monthly progress updates if you offered them. Closeout typically arrives only after the FDA verifies corrections — often at the next inspection. Companies that treat the response as the finish line usually meet the FDA again; companies that treat it as month one of a remediation program tend to close out. Track how similar letters progressed for companies in your niche with our free warning-letter lookup, and get every new letter in your inbox with GMPSignal alerts.
Frequently asked questions
How long do you have to respond to an FDA warning letter?
15 working days from receipt. If a complete response is impossible in that window, submit an interim response with a dated plan — silence or lateness is treated as refusal and invites escalation.
What should an FDA warning letter response include?
Restate each violation, provide a root-cause analysis, commit to a CAPA plan with dates and owners, describe interim risk controls, attach documentary evidence, and address whether the failure could exist elsewhere in your operations.
What happens if the FDA rejects your response?
Escalation options include re-inspection, import alert (detention of shipments), seizure, injunction, or a consent decree. Most escalations trace back to generic responses, missed commitments, or unaddressed distributed product.
Do you need a consultant to respond to a warning letter?
Not always, but third-party expertise adds credibility for systemic findings like data integrity or sterility assurance. The FDA still holds your own quality unit responsible regardless of who writes the plan.
Get new FDA warning letters in your inbox or Telegram
GMPSignal watches FDA enforcement daily and sends you a clean brief — device, drug and food streams. Free tier available.